Economy/Home · Economy

GTG Bio Surges Over 15%... Shihan Investment & Securities: "UBT Evaluation Deal Raises Expectations for Full Contract with Global Pharma"

GTG Bio (456160) surged more than 15% on the morning of the 21st. The stock is trading at 42,650 won, up 5,650 won (15.27%) from the previous session. Against this backdrop, Shihan Investment & Securities analyzed that the evaluation contract for a long-acting obesity treatment has increased the li

Wooil Shim
Staff Reporter
3 min read
GTG Bio Surges Over 15%... Shihan Investment & Securities: "UBT Evaluation Deal Raises Expectations for Full Contract with Global Pharma"
CBC News

GTG Bio (456160) surged more than 15% on the morning of the 21st. The stock is trading at 42,650 won, up 5,650 won (15.27%) from the previous session.

Against this backdrop, Shihan Investment & Securities analyzed that the evaluation contract for a long-acting obesity treatment has increased the likelihood of a full contract with a global pharmaceutical company.

Shihan Investment & Securities focused on GTG Bio's signing of an evaluation contract with UBT for a long-acting obesity treatment. The firm assessed that this deal has raised the likelihood of leading to a full contract with a global pharmaceutical company. It also noted that expectations for additional technology transfers and collaborations are growing, driven by the clinical data of UBT251 and the validation of the InnoLAMP platform.

In particular, the securities firm projected that consecutive full contracts with major global pharmaceutical companies, including Novo, will act as key stock price catalysts going forward.

[This article is provided for informational purposes for investment reference and does not recommend the purchase or sale of any specific stock. Content is subject to change depending on market conditions. Investment decisions and any resulting responsibility rest with the investor. AI assisted in part.]

Wooil Shim
Staff Reporter

CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.